ReviewFrontiers in neuroscience2020

The Current State-of-the Art of LRRK2-Based Biomarker Assay Development in Parkinson's Disease.

Hardy J Rideout et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.